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Abstract. P19 embryonal carcinoma cells provide an
in vitro model system to analyze the events involved in
neural differentiation. These multipotential stem cells
can be induced by retinoic acid (RA) to differentiate
into neural cells. We have investigated the ability of
several variant forms of the protein-tyrosine kinase
(PTK) pp60src to modulate cell fate determination in
this system. Normally, P19 cells are induced to
differentiate along a neural lineage when allowed to
form extensive cell-cell contacts in large multicellular
aggregates during exposure to RA. Through analysis
of markers of epithelial (keratin and desmosomal pro-
teins) and neuronal (neurofilament) cells we have
found that RA-induced P19 cells transiently express
epithelial markers before neuronal differentiation. Un-
ELL-cell signals are important regulators of cell fate
(45) and receptors that couple to protein-tyrosine
kinases (PTKs)' are one class of mediators of these
signals (56) . PTKs have been implicated in events regulating
neuronal differentiation and survival (4, 29) . We have inves-
tigated the effect of pp60src PTKs on a neuronal cell fate de-
cision in an in vitro model system. In most cells the c-src
gene codes for a 60 kD phosphoprotein which has protein-
tyrosine kinase activity (termed pp60`-src). However, neu-
rons from the central nervous system express a variant form
of pp60c-s- (8) that contains a six-amino acid insert due to
alternate splicing of the c-src mRNA which codes for
pp60`-src+ (38, 43) . The v-src gene codes for the transform-
ing protein of Rous sarcoma virus, pp60-src. The pp60°-src
protein is a mutant variant of pp60- that is constitutively
activated, escaping the negative regulation of pp60°-src that
normally occurs in cells (11, 25).
The murine P19 embryonal carcinoma cell line (44) offers
an in vitro system for investigating mechanisms of neurogen-
esis and the roles of candidate regulatory proteins such as
pp60`-src. P19 cells have characteristics of a multipotential
1. Abbreviations used in this paper: DP, desmoplakin; NF-M, middle mo-
lecular weight neurofilament protein; PTK, protein-tyrosine kinase; RA,
retinoic acid.
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der these inductive conditions, expression of pp60-rc
or expression of the neuronal variant pp60c-srcl inhibited
neuronal differentiation, and resulted in maintained ex-
pression of an epithelial phenotype. Morphological
analysis showed that expression of pp60src PTKs results
in decreased cell-cell adhesion during the critical cell
aggregation stage of the neural differentiation proce-
dure. The effects of pp60-rc on cell fate and cell-cell
adhesion could be mimicked by direct modulation of
Call-dependent cell-cell contact during RA induction
of normal P19 cells. We conclude that the neural lin-
eage of P19 cells includes an early epithelial inter-
mediate and suggest that tyrosine phosphorylation can
modulate cell fate determination during an early
cell-cell adhesion-dependent event in neurogenesis.
stem cell . When P19 cells are introduced into mouse em-
bryos they participate in the development of most tissues
(58). P19 cells can be induced to differentiate into neurons
in vitro by a combination of exposure to retinoic acid (RA)
and cell aggregation (28) . Undifferentiated P19 cells have a
low level of pp60°-, whereas these cells express a high
level of the neuronal variant pp60°-src* after neural differen-
tiation (41) . Retroviral transduction ofthe v-src genehas pre-
viously been used to immortalize committed neural cellsiso-
lated from developing animals (10). In P19 cells, v-src has
been shown to block neurogenesis (5) . However, in primary
sympathetic neurons (23) and PC12 cells (2) pp60°-s- pro-
motes neuronal differentiation. These apparently contradic-
tory observations may be reconciled iftyrosine phosphoryla-
tion has different effects at different points in the neural
lineage.
Neural differentiation of P19 cells is promoted by the es-
tablishment of extensive cell-cell contact when cells are
grown as aggregates during exposure to RA (44). In con-
trast, P19 cells exposed to RA in the absence of extensive
cell-cell contact differentiate into cells with a flattened mor-
phology, some ofwhich have detectable keratin intermediate
filaments (48). The molecules involved in the cell-cell con-
tact of differentiating P19 cells in vitro have not been exten-
sively analyzed. A predominant calcium-dependent cell-cell
1019adhesion molecule of the early mouse embryo (66) and P19
cells (49) is E-cadherin. E-cadherin expression is lost when
most cell types differentiate, but many epithelial cells retain
E-cadherin (66) . E-cadherin-mediated adhesion is thought
to be at the beginning of a cascade of cell adhesion-depen-
dent events in the establishment of extensive cell-cell con-
tactsand epithelialpolarity (57). Neural commitment occurs
in the embryonic ectoderm and neural differentiation con-
tinues in neuroepithelia. Results concerning the role of
cadherins in other epithelia may be relevant to neural induc-
tion in ectoderm in vitro and P19 cells in vitro. In MDCK
epithelial cells, pp60,-s- disrupts cell-cell adhesion at the
intercellular junctional complex where E-cadherin is local-
ized (69) . Similarly, in lens epithelial cells, pp60v-s- causes
deterioration of N-cadherin-rich adherens junctions (68).
These alterations in cell-cell contact due to pp60v-s- in epi-
thelial cells suggest that pp60v-s- might also decrease
cell-cell adhesion of P19 cells.
We have investigated the effect of over-expression of
pp60c-s- and further investigated the effects of pp60°,- on
the neural differentiation of P19 cells. During the course of
these investigations we found that stock (parental) P19 cells
transiently express an epithelial phenotype during RA-
treatment of cell aggregates, before expression of a neuronal
phenotype. Both pp60,,"- and pp60°-s--expressing P19
cellsretain the capacity for RA-induced epithelial differenti-
ation, but they have a reduced capacity for neuronal differen-
tiation. The pp60v-s"- and ppó0°--expressing P19 cells also
display reduced cell-cell adhesion in RA-treated aggregates.
Reduction of cell-cell adhesion and inhibition ofneurogene-
sis in RA-treatedstock cell aggregates couldalso be achieved
by culturing the aggregates in medium with a low concentra-
tion of calcium. These results raise the possibility that the
pp60t"-mediated block of neuronal differentiation may be




The Endo-A keratin-reactive TROMA-1 mouse monoclonal IgG (30) was
hybridoma culture supernatant obtained from Rolf Kemler, Max-Planck,
Tubingen. The anti-E-cadherin rabbit antiserum was also obtained from
RolfKemler. This antiserumwas produced using mouse E-cadherin as anti-
gen as described previously (67). The rabbit antidesmoplakin antiserum
was prepared as previously described (55). The anti-pp60"° mouse mono-
clonal IgG 327 (39) was purified from ascites fluid. 327 reacts with mouse
and chicken pp60". The chicken specific anti-pp60Y' mouse monoclonal
IgG EC10 (54) was from hybridoma culture supernatants. The stem cell-
reactive anti-SSEA-1 mouse monoclonal IgM (62) was an ascites fluid ob-
tained from Barbara Knowles, Wistar Institute. The antineurofilament
mouse monoclonal IgG was RM0308 (33) hybridoma culture supernatant
obtained from Virginia Lee, University of Pennsylvania. The anti-
phosphotyrosine-reactive mouse monoclonal IgG was purified PY20 (19)
obtained from ICN Biomedcals (Costa Mesa, CA). Antiglial fibrilary
acidic protein rabbit antiserum was from DAKO Corp. (Carpinteria, CA).
Antidesmin mouse mAbwas from Labsystems (Helsinki, Finland). The an-
tivimentin rabbit antiserum was previously described (51).
Plasmids and Viruses
For expression plasmids chicken c-sic (37), c-sic+ (38), or Schmidt-Rupin
A strain of RSV v-sic sequences (13) were used allowing easy detection of
plasmid expressed pp60Y' using mAb EC10. Plasmids pLNSL7v-sic,
pLNCXc-sic+, and pLNCXc-sic were constructed by ligation of sic into
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the C1al sites of pLNCX and pLNSL7 (46). Psi-2 cells were transfected
using the calcium phosphate precipitation technique (12) with the retroviral
packaging signal containing plasmids. Each plasmid has theneogene under
the control of the retroviral long terminal repeat. Transfected clonal lines
were selected by growth of cells in G418. Viral culture supernatants were
stored at -80°C and viral titers assayed on NIH3T3 cells. Viral superna-
tants from Psi-2 lines which had good titer and gave expression ofpp60'
in 3T3 cells were used for infection of stock undifferentiated P19 cells. In-
fections were performed by adding viral supernatants to cell cultures in the
presence of 8 Ag/ml polybrene.
Cells
The P19 cells were mouse P19SI801AI cells obtained from Joel Levine,
SUNY, Stony Brook. P19 cells were cultured in high glucose DMEM as
described previously (35) except for experiments involving immuno-
histochemical detection of Endo-A keratin expression for which DMEM/
F12 and gelatin-coated coverslips were used as described (48). The cells
grewmoreslowly underthelaterconditions, andkeratin filamentswere eas-
ierto visualize by staining. Exposureof monolayer cultures to retinoic acid
was as described (48). F9 cells were grown under the same conditions as
P19 cells. RA was included in culture media at one feeding and the cells
were refed after 2 d with normal medium. Neuronal differentiation was
achieved by RA treatment of cells allowed to aggregate in bacteriological
grade culture dishes according to theprotocol of Levine and Flynn (35) ex-
cept that poly-D-lysine was used during growth in serum-free medium. For
growth ofcells in low calcium medium and metabolic labeling experiments,
dialyzed FCS was used. Mouse NIH3T3 (ATCC) and Psi-2 (42) cells were
maintained in high glucose DMEM with 10% calf serum. G418-resistant
cells were selected in 400,ug/ml G418 and maintained in 200 pg/n-d G418
until the last feeding before viral supernatant collection (Psi-2 cells) or 2 d
before RA treatment for P19 cells. Initial experiments involving neuronal
differentiation were performed with four sublines each of pp60`-"- and
pp60"-s"-expressing P19 cells. For further analysis (see Figs. 5, 7 C, F,
and G, 8, E-G, and most E-cadherin experiments) two sublines designated
CXcsrc+E7 and SLvsrc3E were used. These lines were shown to have sta-
ble expression ofpp60s" from their retrovirally introduced sic genes in the
absence of continued G418 selection. MDCK cells were maintained as de-
scribed previously (51) .
Phosphorylation
In vitro protein-tyrosine kinase (PTK) assays were performed following im-
munoprecipitation of pp60s" as described (8) except that Mn' was used
instead of Mg' in some experiments and protein A-Sepharose was used
instead of S. aureus cells. For quantitation of in vitro PTK activity Mg++
was used, the reaction was for 10 min at 4°C, and 32p incorporated into
enolase was directly measured inexcised gel slices. RIPA buffer (I% deoxy-
cholate, 1% TX-100, and 0.1% SDS, 160 mM NaCl, 5 mM EDTA, and 10
mM Tris, pH 7.2) was used to solubilize pp60".
Quantitative DeterminationofProteinLevels
Transferof proteins to nitrocellulose and detection of specific proteins with
antibodies and 1251-protein A was performed as described previously (55),
except that transfer currents were varied from 0.5 to 0.75 Amp-h depending
on the Mr of the protein to be detected. For desmoplakin experiments pro-
tein solubilization conditions with nonionic detergent (CSK, contains 0.5%
TX-100)and SDSwere asdescribed (55). For detectionofphosphotyrosine-
containing proteins, cells were removed from culture dishes by scraping in
hot SDS buffer (containing 2% SDS) as described (20). For anti-pp60°`
and antiintermediate filament protein blots, cell pellets were frozen at
-80°C and then were solubilized in SDS buffer. For keratin experiments,
leupeptin was included to inhibitproteolysis. Solubilized protein was deter-
mined using the Bio-Rad protein assay (Bio-Rad Laboratories, Richmond,
CA) and equal amounts of protein were electrophoresed for each sample.
For blots probed with mouse mAbs, an incubation with purified rabbit-
antimouse antibodies (Boehringer Mannheim Biochemicals, Indianapolis,
IN) was done after the primary antibody incubation. For quantitation,
pieces of nitrocellulose were cut from blots and 1251 counted directly or au-
toradiograms were scanned with a densitometer. For estimation of protein
M r according to migration distance during SDS-PAGE, prestained protein
standards (Bio-Rad Laboratories) wereused: myosin (213 kD), fl-galactosi-
dase (122 kD), BSA (80 kD), and ovalbumin (50 kD). For quantitation of
cell surface E-cadherin, cells were washed with PBS with 1 mM Ca" and
1020incubated for 8 min at 37°C in the same buffer with 600 gg/ml trypsin
(Worthington Biochemical Corp., Freehold, NJ) . PMSF and soybean tryp-
sin inhibitor were added, cells were sedimented, and anti-E-cadherin anti-
serum-reactive protein was immunoprecipitated from the cell supernatants .
Immunoprecipitated proteins were resolved by SDS-PAGE and transferred
to nitrocellulose . Cell surface E-cadherin was detected by probing the
nitrocellulose with the same anti-E-cadherin antiserum . The 84-97-kD pro-
teolytic fragments are derived from the extracellular domain ofE-cadherin .
Immunofuorescence
For SSEA-1 detection, cells were notfixed before staining . ForSSEA1 visu-
alization, a purified goat antimouse antibody that reacts with IgM obtained
from Boehringer Mannheim was used . This antibody is biotin conjugated
and was visualized with Avidin-FITC from Boehringer Mannheim . For
middle molecular weight neurofilament protein (NF-M), glial fibrilary
acidic protein, keratin, and vimentin intermediate filament staining, cells
were fixed with acetic acid/ethanol (5:95%) . Mouse IgGs were visualized
with a purified goat antimouse lissamine rhodamne conjugated antibody
from Boehringer Mannheim . E-cadherin and desmoplakin staining was
with methanol-fixed cells . Primary rabbit antibodies were visualized with
rhodamine-conjugatedaffinity-purified goat antirabbit F(ab) from Accurate
Chemical (Westbury NY) or FITC-conjugated affinity-purified swine
anti-rabbit IgG from DAKO. For aggregate staining, aggregates were em-
bedded in gelatin and sectioned (10 Am) before staining. All cell staining
was done with cells grown on poly-D-lysine-coated glass coverslips except
for Endo-A keratin staining which was done with cells on gelatin coated
coverslips .
Results
Expression ofpp60v-src5 orppWc-src in P19 Cells
To examine the effects of expression of pp60 v-src and over-
expression of pp60` -s- in P19 cells, sublines were generated
after infection of undifferentiated cells with recombinant
murine retroviruses carrying the avian v-src and c-src genes.
AnMLVderived retroviral vector carrying an internal cyto-
megalovirus early gene promoter (LNCXc-src+) was used
for expression of ppb0°s- (46), and a similar vector with
an internal SV40 early promoter (LNSL7v-src) was used to
generate P19 sublines that express pp60°,- . Expression of
pp60- by P19 cells was quantitated using an in vitro PTK
assay following immunoprecipitation of pp6(Y- from in-
fected P19 cells (Fig . 1 A, lanes 3-8 and B, lanes 3-5) . Based
on 32P incorporation into the exogenous substrate enolase,
the pp60°° kinase activities of two LNCXc-src+-infected
and two LNSL7v-src-infected P19 sublines were 10.5-, 6.6-,
36-, and 43-fold higher than that of stock (noninfected) un-
differentiated P19 cells (Fig. 1 C, lanes 1-5) .
The relative levels of pp60 ,- in two P19 sublines were
also quantitated using an immunoblot assay (Fig . 2 A) . The
amount of pp60s- in cells of subline CXcsrc+E7 (lane 2) is
eightfold higher than that of endogenous pp6(Y- in
undifferentiated stock P19 cells (lane 1) . A similar level of
pp60`,- is expressed after neuronal differentiation of stock
P19 cells (41) . The level of pp60,- in subline SLvsrc3E
(lane 3) is fivefold higher than that of stock P19 cells . The
high in vitro PTK activity of pp6(Y- from pp60v-sre-
expressing P19 cells (Fig . 1 C) is due to the high specific ac-
tivity of pp60° -src (11, 25) . NIH3T3 cells infected with the
same retroviruses displayed significantly higher levels of ex-
pression of these pp60°-- variants (Fig . 1 A, lane 1; B, lane
6 ; and C, lanes 7and 8), suggesting that both theCMV and
SV40 early promoters are less effective in promoting tran-
scription in P19 cells, as expected from results with other
embryonal cells (21) . TheCMV promoter gives the best ex-
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Figure 1. In vitro PTK activities of P19-O1AI sublines . pp60 src
was isolated from solubilized cell proteins by immunoprecipitation
and reacted with 31P7-ATP as described in Materials and Meth-
ods . NIH3T3 cells are shown for comparison inA-C (lanes 1, 6,
and 6-8 respectively) . mAb EC10 was used for lanes 2-6 in B.mAb
327 was used for A and C and lane 1 of B . (A) LNCXc-src+ in-
fected 3T3 cells (lane 1), uninfected P19-OlAl cells (lane 2), cells
from pooled LNCXc-src+ G418 resistant colonies (lane 3), and
five LNCXc-src+ sublines (lanes 4-8) . (B) Uninfected cells (lanes
1 and 2), cells from pooled G418 resistant LNSL7v-src colonies
(lane 3), two LNSL7v-src sublines (lanes 4 and 5), and LNSL7v-src
infected 3T3 cells (lane 6) . (C) Gel for quantitation of in vitroPTK
activities . LNCAc-src+ sublines D and E (lanes 1 and 2), LNS-
L7v-src sublines 4 and 3 (lanes 3 and 4), P19-OlAl stock cells (lane
5), uninfected 3T3 cells (lane 6), LNCXc-src+ 3T3 cells (lane 7),
LNSL7v-src 3T3 cells (lane 8) . 'ZP incorporation into enolase in
lanes 7 and 8 was 31- and 72-fold higher than in lane 6. The exoge-
nous substrate enolase was included in the phosphorylations forB
and C ForA-C all lanes are from the same autoradiogram ; in A
and C some intervening lanes were removed . pp60src bands (some
faint) could be seen in the original autoradiograms for all antibody
327 immunoprecipitates .
pression of pp60sr° in P19 cells and allows investigation of
the effect of a moderately elevated level of pp60`-on neu-
rogenesis.
The relative levels ofphosphotyrosine-containing proteins
of stock, pp60°,-expressing, and ppó0°- -expressing P19
cells were determined by probing an immunoblot with a
mAb that recognizes phosphotyrosine (Fig . 2 B) . Expres-
sion of pp60`-s-+ does not result in a general elevation of
phosphotyrosine levels in P19 cells (lane 2), as expected
from results obtained from over-expression of pp60`-s- and
pp60c-src+ in other cell types (11, 25, 36) . However, expres-
102 1Figure 2 . Levels of expres-
sion of ppó0°n and detection
ofphosphotyrosinecontaining
proteins inP19-OW sublines .
Cells from undifferentiated
monolayer cultures of stock,
subline SLvsrc3E, and subline
CXcsrc+E7 were solubilized
with SDS buffer as described
(20).100 Wgproteinfrom each
sample was resolved on a 10
(A) or 5% (B) acrylamide gel
and then the region of the gel
between the prestained oval-
bumin andBSA standards (A)
or thewhole gel (B) was trans-
ferred to nitrocellulose. (A)
Anti-ppó0src mAb 327 was
used to detect pp6(src in stock
P19-OlAl cells (lane 1), sub-
line CXcsrc+E7 (lane 2), and
subline SLvsrc3E (lane 3) . In two experiments, CXcsrc+E7 cells
had 7.8- and 7.9-fold more pp60$- than stock cells ; SLvsrc3E cells
had 4.8- and 5.5-fold more. Lanes 2 and 3 were reordered from the
original autoradiogram to match the lane order in B . (B) Anti-
phosphotyrosine mAb PY20 was used to detect phosphotyrosine
containing proteins of stock (lane 1), subline CXcsrc+E7 (lane 2),
and subline SLvsrc3E (lane 3) cells. Positions of prestained molec-
ular mass markers myosin (213), 0-galactosidase (122), andBSA
(80) are shown .
sion of pp60"- caused a 25-fold elevation in phosphotyro-
sine levels (lane 3) .
The expression of pp60"- s-and pp60°-ar,+ does not cause a
dramatic change in the morphology of P19 cells grown as
monolayers (Fig . 3) . Most of the cells in stock cultures ad-
here to each other in groups as "islands; while a minority
are isolated (Fig. 3 A) . Slight alterations in cell packing in
the pp60°-- and pp60-.c+-expressing P19 cell cultures
were observed . The pp60c-s--expressing P19 cell lines had
a slightly larger number of isolated cells (Fig. 3 B) . Fewer
pp60-s-expressing P19 cells grow as isolated cells, and
the cells in islands are more evenly packed at the edges of
the islands (Fig . 3 C) . In contrast to non-RA-treated stock,
pp60" - src-expressing, and pp60c -s "c+-expressing P19 cells,
P19 cells exposed to RA as sparse monolayers have an al-
tered morphology (Fig. 3 D) . RA-treated P19 cells become
flatter (phase dark) andmore spread (1.6-fold more cells per
unit area) on the culture surface . The subtle changes in cell
packing observed for pp60-- and pp60`--expressing
P19 cells do not resemble the dramatic change in morphol-
ogy observed after RA-induced differentiation .
We considered the possibility that pp60°-arc and pp60°-
expression could cause changes in the differentiation state of
P19 cells in the absence of morphological changes . Embry-
onal carcinoma cells express embryonic antigens that are lost
after differentiation . The effects of pp60- and pp60c-arc+
expression on P19 cell differentiation were assessed by im-
munofluorescence microscopy and antibody to stem cell
marker SSEA-1 (Fig. 3, E-H) . Most cells of P19 cultures that
have not been exposed to RA express the SSEA-1 antigen
(Fig . 3 E) . RA treatment leads to the loss of expression of
embryonic antigen SSEA-1 (Fig. 3 H), as previously
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Figure 3 . Morphology and SSEA1 embryonic antigen of pp60 °-src-
and pp60`-src+-expressing P19-OIAI cells . Morphology by phase-
contrastmicroscopy of undifferentiated stock (A), pp60"'-express-
ing (B), pp60-src-expressing (C), and differentiated stock P19-
OlAl cells from RA-treated monolayer culture (D) . For A-D, cells
were grown under normal culture conditions . For immunofluo-
rescence detection of the SSEA1 antigen, cells were grown on
poly-D-lysine-coated coverslips. SSEA1 embryonic cell antigen of
undifferentiated stock (E), pp60-src+-expressing (F), pp60- rc-
expressing cells (G), and RA-treated monolayer culture cells (H) .
One cell that had not lostSSEA1 expression in response to RA can
be seen at the left edge ofH . This cell had retained a rounded mor-
phology and rested on top of flatter, SSEA-1-negative cells . Bars :
(A-D) 200 um ; (E-H) 10 Am .
reported (48) . SSEA-1 antigen expression is retained by
pp60-rl-expressing P19 cells that are not exposed to RA
(Fig . 3 F) . In contrast, the ppó0°--expressing P19 cells do
not express SSEA-1 antigen even in the absence of exposure
to RA (Fig . 3 G) .
Expression ofpp60-s^c+ orpp60-rc Interferes with
Neuronal Di fferentiation ofP19 Cells
To examine the effects of pp60` -src+ and pp60- on neuronal
differentiation, stock, pp60-.c+-expressing, and pp60°-src_
expressing P19 cell lines were induced to differentiate by ex-
posing the cells to RA and allowing the cells to form exten-
sive cell-cell contacts in floating aggregates. After 4 d, the
1022Figure 4 . Morphology and
NF-M of P19-OIAI cells after
neuronal differentiation. Mor-
phology of P19 cells that had
been treated for neural differ
entiation ; stock (A), pp60`-Trc+-
expressing, (B) pp60-rc-ex-
pressing cells (C), and G418
resistant (only) cells (D) .
Phase-bright, rounded, self-
adhering (closed arrows) and
phase-dark, flat (open arrows)
cells are indicated in A. In B
a region of a coverslip with
few neuronal cells is shown :
other areas on the same cover-
slip had more phase-bright
cells . StockP19 cells exposed
to RA as sparse monolayers
then aggregated and further
processed as for neural differ-
entiation (E) . Stock cells that
wereRA treated andaggregated
in low calcium (50 ,,M Ca++)
culturemedium then processed
forneuronaldifferentiation (F).
Cells were fixed at 60h(A-F)
or 7d (G-J) after disaggrega-
tion and culture on coverslips .
Immunofluorescence detection
of NF-M (GI) ; stock P19
cells (G), pp60--expressing
cells (H), pp60c-j-+-express-
ing cells (I), and correspond-
ingNomarsky image forI(J) .
ForIand J, a sparse region of
the coverslip is shownforeasy
identification offlat andround
cells. ForH, adense region of
the coverslip is shown which
contained a rare cell with
a neurofilament-positive pro-
cess . Bars : (A-F) 100 jm ;
(GJ) 20 um .Figure S. NF-M levels in P19-OlAl cells. Cell proteins solubilized
with SDS were resolved by SDS-PAGE and proteins in the region
of the gel between the ß-galactosidase (122) and myosin (213) pre-
stained standards were transferred to nitrocellulose . NF-M (esti-
matedM 143,000) was detected by probing the nitrocellulose with
anti-NF-M antibody and 12sí-labeled protein A. Undifferentiated
stock (lane 1), pp60°-Src*-expressing (lane 2), and pp60°-Src-express-
ing cells (lane 3) . Stock cells exposed to RA as sparse monolayers
then treated as for neuronal differentiation (lane 4) . In three ex-
periments these cells had 3, 5, and 3% of the NF-M level in
stock cells . Cells treated according to the standard neuronal dif-
ferentiation procedure for stock (lane S), pp60`-Srcl-expressing
(lane 6), and pp60--expressing (lane 7) P19 cells . In three ex-
periments pp60` -'rc+-expressing cells had 52, 87, and 53% of the
NF-M level in stock cells ; for pp601src-expressing cells the values
were <l, <l, and 7% . Stock P19 cells exposed to RA and aggre-
gated in medium with 50 ,.M Cal and treated as for neuronal dif-
ferentiation (lane 8) . In three experiments these cells had <l, <l,
and 7 % of the NF-M level in stock cells . Cells were harvested 11 d
after exposure to RA .
aggregates were dissociated with trypsin and the cells plated
in serum-free N2 medium (35) . As previously reported, neu-
ronal differentiation of stock P19 cells results in a character-
istic morphology ; self-adhering, rounded (phase bright) cell
bodies with long processes (Fig . 4 A) (35, 44) . Neurofila-
ment expression (Fig . 4 G and Fig . 5, lane S) confirmed the
identity of these cells as neurons. A small number of glial
fibrilary acidic protein-positive cells are detected in these
cultures (Fig . 6 A), as described (35) . P19 sublines selected
for resistance toG418 after infection with virus that does not
include a src gene were found to undergo the characteristic
neuronal differentiation (Fig. 4 D) .
pp60-rc+-expressing P19 sublines that were taken through
the steps ofthe neuronal differentiation procedure showed an
abnormal pattern of differentiation . Although many neuro-
filament-positive cells with long processes were present in
these cultures, there were also many flat (Fig. 4 B), neuro-
filament-negative cells (Fig . 41) . Very few of these spread,
phase dark cell bodies were observed in the cultures of
differentiated stock P19 cells (Fig . 4, A and D) . Most
differentiated pp60v-s-expressing P19 cells have a flat-
tened, nonneuronal morphology (Fig . 4 C) . Very few
neurofilament-positive cells (Fig . 4 H) or glial fibrilary
acidic protein-positive cells (not shown) were detected in
cultures of pp60°-s.°-expressing P19 cells which were in-
duced for neuronal differentiation . However, some partially
rounded cell bodies with short extensions were present in
these cultures . These cells did not have neurofilaments as de-
termined by immunofluorescence (Fig . 4 H) . P19 sublines
selected for resistance to G418 after infection with a
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Figure 6. Immunofluorescence detection of cell-type markers . A
glial fibrilary acidicprotein-positive cell after neural differentiation
of P19 cells (A) . Cells were stained for Endo-A keratin filaments :
P19 cells treated with RA in monolayer culture (B and C) and
MDCK cells (D) . The positions of two P19 cells that did not have
detectable keratin filaments are indicated (B) . Cells were stained
for desmoplakins : undifferentiated P19 cells in monolayer culture
(E), RA-treated P19 cells in monolayer culture (F),RAtreated and
aggregated P19 cells (G), and MDCK cells (H) . For G, aggregates
were embedded and sectioned before staining. Cells were stained
for E-cadherin: undifferentiated P19 cells (1) and P19 cells exposed
to RA in sparse monolayer culture (J) . Cells were stained for vi-
mentin : stock P19 cells (K) or MDCK cells (L) . Bars : (A-D) 20
pm ; (E-H) 10 /m ; (1--L) 20 pm .
pLNCXc-src virus (expressing the nonneuronal pp60`-src)
also yielded more flat cells after the neuronal differentiation
procedure than do stock P19 cells (not shown) .
The levels of middle molecular weight neurofilament pro-
tein (NF-M) in non-RA-treated cultures of pp60" -src- and
pp60°--expressing P19 sublines were quantitated relative
to the level in uninfected P19 cells (Fig . 5, lane 1) . Neither
pp60v-s- or pp60c-s
- alone (Fig . 5, lanes 2 and 3) induced
expression of NF-M in the monolayer cultures, as reported
previously for pp60"-s- (5) . Stock P19 cells differentiated as
aggregates with RA displayed high levels of NF-M (Fig . 5,
lane S) . Cultures of differentiated pp60°-s- +-expressing P19
cells displayed a 36% reduction (Fig. 5, lane 6) inNF-M pro-
tein relative to the stock cell level . In contrast, very low lev-
els ofNF-M protein were detected in differentiated cultures
of pp60--expressing P19 sublines (3% of the stock cell
level ; Fig . 5, lane 7) . Thus, pp60 ,-s- expression in undif-
ferentiated P19 cells greatly decreases the capacity for RA-
induced neuronal differentiation, as reported previously (5),
and pp60` -
src+ expression interferes with neuronal differenti-
ation in -36% (based on NF-M levels) to 44% (based on
1024Figure 7 . Keratin and desmo-
plakinexpressioninP19-OIAI
cells . Cellproteins solubilized
as described in Materials and
Methods were resolved by
SDS-PAGE and transferred to
nitrocellulose . Keratin and
desmoplakins were detected
by probing the nitrocellulose
with antikeratin or antidesmo-
plakin antibodies and I'll-
labeled proteinAfollowed by
autoradiography (A, B, C, F,
and G) . ForD and E, meta-
bolically labeled desmoplak-
ins were immunoprecipitated,
resolved by SDS-PAGE, and
visualized by autoradiography.
(A) Undifferentiated stock (lane
1), pp60`--+-expressing (lane
2), pp60--expressing (lane 3)
P19 cells . Stock P19 cells in
sparse monolayer culture ex-
posed to RA and then treated
as for neuronal differentiation
(lane 4) . Cultures processed
for neuronal differentiation ;
stock (lane 5), pp6a
-src+-ex-
pressing (lane 6), pp60°-src-
expressing (lane 7), and stock
P19 cells aggregated in 50)M
Call and treated as for neu-
ronal differentiation (lanes 8) .
For lanes 4-8 cells were har-
vested 11 d after exposure to
RA . (B) Comparison of kera-
tin levels in RA-treated mono-
layer P19-01A1 cells (lane 1),
non-RA-treated P19-OIAl cells
(lane 2),and RA-treated mono-
layer cultures of F9 cells (lane
3 . (C) Comparison of keratin
levels in 2-d P19 cell aggre-
gates: RA-treated (lanes 1, 3,
and 5) and non-RA-treated
(lanes 2, 4, and 6) . Stock
(lanes 1 and 2), pp60°-$--ex-
pressing (lanes 3 and 4), pp60-rc-expressing (lanes 5 and 6) cells. (D)
35S-methionine-labeled (3-h labeling) stock P19 cells grown for
2 d as floating aggregates . Detection of DPI and DPII in CSK-soluble (lane 1) and CSKresistant (lane 2) fractions of aggregates grown
in the absence of RA . DPI and DPII in CSK-soluble (lane 3) and CSK-resistant (lane 4) fractions of RA-treated cells . Approximately
equal numbers of cells were labeled and incorporation of 35S-methionine into total protein was similar for aggregates with and without
RA . The solubilized protein samples were split in half and also used for Fig. 9F . (E) Comparison of desmoplakins in CSK-soluble (lane
1) and CSK-resistant (lane 2) fractions of 35S-methionine-labeled (2-h labeling)MDCK cells . (F) Desmoplakin levels in non-RA-treated
monolayer cultures of stock (lane 1), pp60-rc+-expressing (lane 2), and pp60°
-src-expressing (lane 3) cells . Desmoplakin levels in RA
treated (lanes 5, 7, and 9) and non-RA-treated (lanes 4, 6, and 8) 2-d-old aggregates of stock (lanes 4 and 5) of pp60
-1-expressing
(lanes 6and 7) and pp601--expressing (lanes8 and 9) cells . (G) Desmoplakin levels in P19 cultures processed for neuronal differentia-
tion : stock (lane 1),pp60°-src+-expressing (lane 2), andpp60°
-arc-expressing (lane 3) cells . Cells were harvested 11 d after exposure to RA .
Gels were 10% or5% acrylamide for keratin(KER)or DPIandDPII, respectively. Positions ofprestained protein standards myosin (213)
and ovalbumin (50) are indicated inD and A, respectively.
keratin levels, seebelow) of thepopulation . The presence of
the phase-dark, flattened cells in both the pp60°
-s-- and
pp60--expressing cell cultures suggested that these PTKs
directed differentiation towards a nonneural lineage .
Expression ofpp60~s~* orpp60- DoesNot Prevent
Epithelial Differentiation ofP19 Cells
The flattened, nonneuronal cells in cultures of RA-treated
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pp60°
-s-- and pp60° -s--expressing P19 sublines (Fig . 4, B
and C) morphologically resemble the nonneuronal cells ob-
tained by exposing stock P19 cells in sparse monolayer cul-
ture toRA (Fig. 4 E) . Cells with aflattened morphology and
keratin intermediate filaments have previously been identi-
fied in P19 monolayer cultures after exposure to RA (48) .
This suggested that the pp60
v-src- and pp60`-s
.c+-expressing
P19 cells might have undergone epithelial differentiation in
1025response to RA under conditions that give neuronal differen-
tiation of stock cells. The epithelial differentiation of these
cells was characterized by analyzing the expression of des-
mosomal proteins desmoplakins I and II (55) and keratin in-
termediate filaments as markers of epithelial differentiation.
Keratins are components of intermediate filaments in epithe-
lial cellsand they are found together with desmosomes only
in epithelial cells (47) . The epithelial differentiation of P19
cells exposed to RA in sparse monolayer culture was also
characterized for comparison.
We examined expression of keratin with the mAb
TROMA-1, which has previously been shown to react with
keratin in P19 monolayers treated with RA (48). Im-
munofluorescence (Fig. 6) and immunoblot assays (Fig. 7)
were used to examine keratin expression. Non-RA-treated
P19 cells have a very low level of keratin (Fig. 7 A, lane 1).
After RA treatment of monolayer P19 cultures, keratin fila-
ments can be detected in some of the cells (Fig. 6, B and C),
as previously reported (48). The increase in mAb TROMA-
1-reactive keratin (estimated M, 56,000) protein after RA
treatment of P19 cells in sparse monolayer culture is shown
in Fig. 7 B (lanes 1 and 2) .
Most of the RA-treated P19 cells (Fig. 6 C) have relatively
few keratin filaments. Unlike RA-treated F9 cells (32), not
all of the RAtreated P19 cells that take on a flattened mor-
phology have detectable keratin filaments (Fig. 6 B) . RA-
treated F9 cells (Fig. 7 B, lane 3) have a higher level of
TROMA-1-reactive keratin than P19 cells (Fig. 7 B, lane 1) .
The keratin filaments that we detect in flat, nonneuronal,
differentiated P19 cells (Fig. 6, B and C) are often not as uni-
formly dispersed throughout the cytoplasm as in RA-treated
F9 embryonal carcinoma cells (24) or MDCK cells (Fig. 6
D) . The keratin filaments of many RA-treated P19 cells are
present in clumps mostly on one side ofthe nuclei rather than
as a well dispersed network throughout the cells.
Cultures of stock P19 cells that have undergone neuronal
differentiation do not have a detectable (by Western blot)
levelofkeratin (Fig. 7 A, lane S), although a very small num-
ber of cells in these cultures have keratin filaments detect-
able by immunofluorescence (not shown). Expression of
pp60c-,,,+ or pp60°-s- in P19 cells maintained without RA
treatment does not induce keratin expression (Fig. 7 A, lanes
2 and 3), as reported previously for pp60°-s- (5). However,
like stock P19 cells (Fig. 7 B, lane 1), cells of pp60`-s-- or
pp60--expressing sublines express keratin after exposure
to RA in monolayer culture (not shown) or when grown as
floating aggregates and treated for neuronal differentiation
(Fig. 7 A, lanes 6 and 7). Unlike stock cells, pp60`-s«*- and
pp60°-s,c-expressing P19 cells continue to express keratin
under conditions which in stock P19 cells result in neuro-
filament expression and very little keratin expression.
Desmoplakins are cytoplasmic, structural proteins of des-
mosomes (55) . Desmoplakin expression was analyzed by
immunofluorescence (Fig. 6) and by immunoblot and meta-
bolic labeling (Fig. 7). In undifferentiated P19 cells, antides-
moplakin antibodies reveal diffuse staining in a peri-nuclear
region of the cytoplasm (Fig. 6 E) . After RA treatment of
P19 cellsin monolayer culture, most ofthe peri-nuclear stain
is dispersed and punctate staining is detected inside cellsand
at sites of cell-cell contacts (Fig. 6 F) . The level of 'SS-
methionine incorporated into desmoplakins is increased (12-
fold in Fig. 7 D, lane 3) in stock P19 cells after RA exposure
as compared to non-RA-treated P19 cells (Fig. 7 D, lane 1) .
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After RA treatment, stock P19 cells have a higher level of
desmoplakins I and II (DPI and DPII) and a fraction of these
desmosomal components is resistant to extraction in buffer
(CSK; see Materials and Methods) containing nonionic de-
tergent (Fig. 7 D, lane 4). These extraction conditions have
previously been used to demonstrate a correlation between
the pool of desmoplakins that is resistant to solubilization
with nonionic detergent (CSK resistant) and assembly into
desmosomes (55) . Compared to MDCK cells (Fig. 7 E), the
P19 cells do not efficiently recruit DPI and DPII into the
CSK-resistant pool. This difference in recruitment correlates
with a higher density of cell-cell interface localized des-
moplakin staining of MDCK cells (Fig. 6 H). These results
are consistent with RA-induced stabilization of some des-
moplakins at cell surface desmosomes between adjacent P19
cells.
Like stock P19 cells, the pp60,-s-- and pp60`- s,C+-express-
ing P19 cells also have elevated levels of desmoplakins af-
ter exposure to RA (Fig. 7 F) . However, in contrast to stock
P19 cells, the cells of pp60-s-expressing and pp60`-s--
expressing P19 sublines have detectable desmoplakin ex-
pression 11 d after exposure to RA (Fig. 7 G, lanes 2 and
3) under conditions that induce neuronal differentiation and
little desmoplakin expression in stock P19 cells (Fig. 7 G,
lane 1). The expression of keratin and desmoplakins in
pp60°-s,c-expressing and pp60--expressing P19 cells cor-
relates with the appearanceofflat, nonneuronal cells in these
cultures under conditions that give neuronal differentiation
of stock P19 cells.
Thus, while not all of the nonneuronal, RA-treated P19
cells express detectable keratin filaments and desmosomes,
a large percentage of the cells do have desmosomes (above)
and keratin filaments, as described previously (48) . These
flat, nonneuronal, differentiated P19 cells display heteroge-
neity in morphology (extent of cell spreading on the sub-
strate) and expression ofkeratin filaments and desmosomes.
Heterogeneity of nonneural RA-treated P19 cells has been
previously described (48, 50, 59). Low levels of RA have
been used to induce muscle cellsin P19 cultures (16) . Using
immunofluorescence, the muscle-specific intermediate fila-
ment protein desmin has not been detected in our P19 cul-
tures. The intermediate-sized filament component vimentin
is detected in non-RA-treated P19 cells (Fig. 6 K), but the
staining is diffuse rather than filamentous (Fig. 6 L), as pre-
viously reported (17). The vimentin staining in P19 cells is
concentrated in a compact region to one side of the cell
nuclei .
Based on results with the marker proteins, we conclude
that pp60,. s- or pp60c-s- expression alonedoes not result in
neuronal or epithelial differentiation of P19 cells. However,
expression of pp60- in P19 cells does result in the loss of
SSEA-1 embryonic antigen. Our results agree with the con-
clusion of Boulter and Wagner (5) that pp60°--expressing
P19 cellslose expression ofstem cellmarkersbut donot com-
mit to a complete differentiation program. Our results with
the epithelial markers show that pp60°-sr°- and pp60°-src+-
expressing P19 cells can respond to RA by differentiating and
attaining an epithelial phenotype.
Transient Expression ofan Epithelial
Phenotype in Retinoic Acid-treated andAggregated
Stock P19 Cells
The expression of an epithelial phenotype of pp60,-s-- and
1026pp60`-Src-expressing P19 cells in long term cultures induced
with RA under the conditions for neuronal differentiation
prompted us to test for an epithelial phenotype in cells of
stock P19 aggregates. RA exposure results in a rapid increase
in keratin levels in floating aggregates of stock, pp60,-src_
expressing, and pp60`-c+-expressing P19 sublines (Fig. 7
C) . Aggregated cells of stock, pp60°-J--expressing, and
pp60-.c+-expressing P19 sublines also respond rapidly to
RA by increasing levels of desmoplakin protein (Fig. 7, D
and F). P19 cells and RA-treated aggregates have punctate
desmoplakin staining throughoutthe entire thickness of the
aggregates (Fig. 6 G) and CSK-resistant desmoplakin (Fig.
7 D, lane 4). Stock P19 cells only transiently express an
epithelial phenotype during the aggregation stage ofthe neu-
ronal differentiation procedure. After disaggregation and
culture in N2 medium most stockP19 cellsdifferentiate into
neurons and lose keratin and desmoplakin expression.
Expression ofpp60°-s-+ orpp605`src Reduces
Cell-Cell Adhesion in Retinoic Acid-treated P19
CellAggregates
Efficient neural differentiation ofP19 cells is achieved by al-
lowing the cells to form floating aggregates during exposure
to RA. Stock P19 cells form tightly compacted aggregates
under these conditions (Fig. 8 A). As seen by phase-contrast
microscopy, the surface of well compacted aggregates is
smooth with few protruding cells. In contrast, pp60"-Sr-
expressing (Fig. 8 C) and pp60c-s-+-expressing (Fig. 8 B)
P19 cell aggregates are less tightly compacted and individual
cell bodies are more protrusive on the surfaces of the aggre-
gates. While stock P19 cell aggregates occasionally adhere
to the bacteriological grade culture dishes, such adherence
was more prevalent in the pp60"-src-expressing cell cultures.
After RA treatment and aggregation, those pp60-express-
ing P19 cells that adhered to the culture dish could be seen
to have short processes (Fig. 8 C, inset) . These processes
are similar to those observed in other nonneural pp60°-S-
expressing cells such as MDCK cells (69) . Interestingly, the
decrease in compaction for aggregates of pp60°--+- and
pp60,-s--expressing P19 cells is observed only in RA-
treated aggregates (compare Fig. 8, E and F).
Cell aggregation was quantitated in a reaggregation assay
(Fig. 8 G). Cells were exposed to RA and allowed to form
floating aggregates for 2 d in medium with a lowerthan nor-
mal concentration of calcium (50 /AM Ca++) . Under these
conditions the aggregates are not compacted and the cells
were disassociated by trituration. The cells were then trans-
ferred to medium with a normal, high level of Ca++ (1.8
mM). The percentage of cells with extensive cell-cell con-
tacts was determined by phase contrast microscopy (see Fig.
8, legend) at times from 0 to 24 h after return to 1.8 mM
Ca++. The pp60c-5.c+- and pp60,-s--expressing P19 cells
have slower rates ofcompaction than stock cells and they do
not attain as high a percentage of compaction by 24 h (Fig.
8 G) . The rates of compaction during the first 8 h for
pp60c,
rc+- and pp60"-s--expressing P19 cells were 62 and
31% of the stock cell rate, respectively.
A cell-cell contact requirement for neural differentiation
of P19 cells has previously been indicated by comparison of
RAtreated cells from aggregates and sparse monolayer cul-
tures (28) . Most stock P19 cellsexposed to RA as monolayers
and then taken through the remaining steps of the neuronal
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differentiation procedure have a nonneuronal morphology
(Fig. 4 E), however, some cells with neuronal morphology
wereobserved. Theextent ofneuronaldifferentiationattained
under these conditions of limited cell-cell contact during ex-
posure to RA was quantitated in terms ofNF-M expression.
Cultures of these cells have a low level of NF-M (4% of the
level in stock P19 cells; Fig. 5, lane 4) and respond to RA
by expressing keratin (Fig. 7 A, lane4) . The decreased neural
differentiation and cell-cell adhesion in aggregates of RA-
treated pp60"--expressing and pp60c-s--expressing P19
cellsand the fact that these aggregated cellshave an epithelial
phenotype suggested that a cell-cell adhesion protein of epi-
thelial cells (such as E-cadherin) might play a critical role
in the neural differentiation of P19 cells.
Inhibition of normal P19 cell-cell contacts by formation
of mixed aggregates with RA-non-responsive cells has pre-
viously been shown to inhibit neural differentiation in RA-
treated aggregates (9) . In similar experiments, we have taken
advantage of the fact that the cell-cell adhesion function of
cadherins can be blocked by lowering the extracellular Ca++
concentration. Stock P19 cells exposed to RA and allowed
to aggregate in medium containing 50 j.M Ca++ do not
form tightly compacted aggregates (Fig. 8D). The decreased
compaction of aggregates formed by RA-treated pp60v-s--
and pp60c-Sr,+-expressing P19 cells in 1.8 mM Ca++ is not as
extreme as for stock P19 cells aggregated in 50 gM Ca++.
Stock P19 cells exposed to RA and aggregated in 50 /M
Ca++, but otherwise treated for neuronal differentiation,
have a nonneuronal morphology (Fig. 4 F) and a low level
of NF-M (2% of the level in stock cells; Fig. 5, lane 8) . P19
cells in the noncompacted aggregates formed in 50 PM
Ca++ respond to RA by expressing keratin (Fig. 7 A, lane
8) . These results suggest that an extracellular calcium-
dependent system may be required during the aggregation
phase of the neuronal differentiation process in order to
achieve neuronal differentiation.
E-cadherinin P19 Cells
The altered cell-cell packing of pp60`-'-- and pp60,-s-
expressing P19 cellssuggested that expression of the cell ad-
hesion molecule E-cadherin might be altered in these cells.
Immunofluorescence reveals E-cadherin staining at cell-cell
contacts of undifferentiated (Fig. 6 1) and RA-treated P19
cells (Fig. 6 J) . Determination of total E-cadherin levels by
Western blot shows that undifferentiated F9 embryonal carci-
noma cells (1) and P19 cells have high levels of E-cadherin
(Fig. 9 A, lanes 1 and 2) . The level of total E-cadherin in
non-RA-treated P19 monolayer cultures is greater (12-fold
greater in Fig. 9 A, lane 2) than the level in cultures that had
been exposed to RA (Fig. 9 A, lane 3), in agreement with
the recent report that levels of E-cadherin mRNA are de-
creasedafter exposure ofcellsto RA (49). The relative levels
of total cell E-cadherin in cultures of stock, pp60--ex-
pressing and pp60°-Src-expressing P19 cells were determined.
Compared to stock P19 cells (Fig. 9 B, lane 1), pp60`-
frc+-
expressing P19 cells have a lower amount of E-cadherin
(65 % ; Fig. 9 B, lane 2). In contrast, slightly more E-cadherin
is present in pp60,-s--expressing P19 cells (1.2-fold more
than stock cells; Fig. 9 B, lane 3) .
Levels ofE-cadherinpresent on thecell surface were deter-
mined by trypsinization of E-cadherin at the cell surface
which gives rise to a large extracellular domain fragment
1027Figure 8 . Decreased compac-
tion of aggregates formed by
retinoic acid-treated pp60° -S^ 1
and pp60°-src-expressing P19
cells . Undifferentiated cells
were allowed to form floating
aggregates for2 d in the pres-
ence ofRA (A-D) . Phase-con-
trast images of large aggre-
gates in culture dishes : stock
P19 cells (A), pp60`-'rc+-ex-
pressing cells (B), pp60-rc-
expressing cells (C), and
stock P19 cells in medium
with 50 pM Cal (D) . A
small ppó0"'rc-expressing cell
aggregate that attached to the
dish with short extensions (C,
inset) . ForE(with RA) andF
(no RA) pp60c-3-*-expressing
cell aggregates were photo-
graphed after mounting on
slides under coverslips. (G)
Time course of compaction of
RAtreated stock (n), ppó0-r*-
expressing (e), and pp60°-'rc-
expressing (o) P19 cells .
Cells were grown for 2 d in
bacteriological grade culture
dishes in medium with RA
and 50 pM Cal. The cells
were transferred to medium
with 1.8 mM Cal at time
zero and cultured forup to an
additional 24 h as floating ag-
gregates . The percentage of
cells which had formed close
cell-cell contacts (compacted)
was determined by triturating
the aggregates, mounting ali-
quots on a hemocytometer,
and counting compacted and
noncompacted cells as viewed
byphase-contrast microscopy.
In compacted aggregates indi-
vidual cells were difficult to
discern (F) while in noncom-
pacted aggregates the borders
between individual cells ap-
pearasphase-brightrings (E) .
Under the conditions for this
reaggregation assay the result-
ing small aggregates were
similar to thoseshown by Lit-
tlefield (40) in his Fig. 4
(A andB) and individual com-
pacted andnoncompacted cells
could be counted . The data
points from three separate ex-
periments (each of which in-
cluded the three cell types)
were combined for this graph.
Bars : (A-D) 50 ,um ; (E andF)
100 pm .Figure 9 . E-cadherin in P19-
OlAl cells. ForA andBcells
were solubilized with RIPA
buffer and equal amounts of
solubilized protein for each
sample were resolvedby SDS-
PAGE and transferred to nitro-
cellulose. The pieces of ni-
trocellulose were probed with
anti-E-cadherin antiserumand
125I-labeled proteinA. (A) Lev-
elsofE-cadherininundifferen-
tiated F9 cells (lane 1), and
undifferentiated P19-01AI cells
in monolayer culture (lane 2) .
P19-OlAl cells exposed toRA
as sparse monolayers (har-
vested 5 d after exposure to
RA ; lane 3) . (B) E-cadherin
levels in stock (lane 1),
pp60°-src*-expressing (lane 2),
and pp601src-expressing (lane
3) undifferentiated P19 cell
monolayers . (C) E-cadherin
levels at the surface of stock
(lane 2), pp60`-s-+-expressing
(lane 3), pp60°-src-expressing
(lane 4) undifferentiated P19
cells . For lanes 2-4 approxi-
mately equalnumbers of cells
were processed for detection
of cell surface E-cadherin as
described in Materials and
Methods . The positions ofthe
84-, 87-, and97-kD E-cadhe-
rin extracellular domain tryp-
tic fragments (tfs) are shown .
In three experiments the level
of cell surface E-cadherin on
pp60--'-expressing cells was
50, 45, and 54%ofthe level on
stock cells; pp60- express-
ing cells had 1.3-, 1.65-, and
1.07-fold more surface E-cad-
herin than stock cells. Cell
surface MDCK E-cadherin
fragment (lane 1) . P19E-cad-
herin,not trypsinized(lane 5) .
(D) Cell surface E-cadherin in
aggregated P19 cells . 2-d aggregates without (lanes 1, 3, and 5) or with RA (lanes 2, 4, and 6) . Control (lanes 1 and 2), ppó0`-'rc+-
expressing (lanes 3 and 4), pp60°-src-expressing cells (lanes 5 and 6) . (E-G) 35S-methionine metabolic labeling of E-cadherin . Cultures
were labeled by growth in 35S-methionine containing medium for 15 min (G), 2 h (E), or 3 h (F) . Cells were solubilized withCSK buffer
and CSK-solubilized proteins that were immunoprecipitated by anti-E-cadherin antiserum are shown . The indicated bands migrate at the
positions of E-cadherin and the coprecipitating a, ß, and y catenins . Fluorographic autoradiography for immunoprecipitates resolved by
SDS-PAGE is shown . (E) Stock (noRA) aggregated P19 cells (lane 1) orMDCK cells (lane 2) . (Lane 3) MDCK cell proteins were solubi-
lized with CSK buffer, resolved by SDS-PAGE, transferred to nitrocellulose, and probed with anti-E-cadherin antiserum . (F) Stock P19
cells were grown as floating aggregates for2dthen labeled ; non-RA-treated cells (lane 1) and cells exposed toRA (lane2) . Approximately
equal numbers of cells were labeled and incorporation of "S-methionine into total protein was similar for lanes 1 and 2. These samples
were split in half and also used for Fig . 7D . All E-cadherin was CSK soluble (not shown) . These lanes arefrom the same autoradiogram ;
some intervening lanes were removed . (G) Cells in monolayer culture without RA were labeled : stock (lane 1), pp60°snl-expressing
(lane 2), and pp60°-sm-expressing cells (lane 3) . pE indicates the position of the E-cadherin precursor. Gels were 5% (E and F) or 7.5%
acrylamide . The positions of prestained size markers ß-galactosidase (122) and BSA (80) are shown for some parts .
(66) . Mature E-cadherin in P19 cells has an apparent M, of
129,000 (Fig. 9 C, lane 5) . TrypsindigestionofMDCK cells
in the presence of calcium releases an 84,000-D, trypsin-
resistant, extracellular domain fragment of E-cadherin that
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canbe detected with antibodies that recognize the extracellu-
lardomain ofE-cadherin (Fig. 9 C, lane 1) . Trypsin digestion
ofP19 cells in monolayerculture (Fig . 9C, lanes2-4)releases
fragments ranging from 87,000 to 97,000 D. These multiple
1029bands are probably partially digested fragments. These frag-
ments react with theantiserumwhich recognizes theextracel-
lular domain of E-cadherin and were used to quantitate the
cell surface E-cadherinof P19 cells. Compared to stock P19
cells (Fig. 9 C, lane 2), less E-cadherinis detected on the sur-
face of pp60`-s. l-expressing P19 cells (50%; Fig. 9 C, lane
3) . In contrast, more E-cadherin is present on the surface of
ppó0°--expressing P19 cells(1.3-fold more than stock cells;
Fig. 9 C, lane 4).
E-cadherin expression in P19 cells was also analyzed by
metabolic labeling. E-cadherinhas previously been shown to
coprecipitate with three lower molecular weight proteins
called a, ß, and y catenin (53). "S-methionine-labeled E-cad-
herin and three associated proteins were coinununoprecipi-
tated from MDCK cells (Fig. 9 E, lane 2). Only E-cadherin
reacts with this antiserum (lane 3), as described previously
(53). E-cadherin from mouse cells (Fig. 9 E, lane 1) has a
slightly lower electrophoretic mobility than that of E-cad-
herin from MDCKcells (129 and 124 kD, respectively) . Pro-
teins migrating at the positions of the a and ß catenins pre-
dominate in P19 cells. The lower level of E-cadherin in
RA-treated P19 cells (Fig. 9 A) correlated with decreased
"S-methionine incorporation into E-cadherin (Fig. 9 F).
The relative differences in E-cadherin levels of
pp60°_src-
and pp60---expressing P19 cells (Fig. 9 B) were also de-
tected in metabolic labeling experiments (Fig. 9 G). In a 15-
min pulse-labeling experiment, pp60°-S--expressing P19
cells synthesized more (2 .8-fold more; Fig. 9 G, lane 3)
E-cadherin than stock (Fig. 9 G, lane 1) or pp60°,,,+-
expressing P19 cells (83 % of the stocklevel; Fig. 9 G, lane
2). At this shorttime aftersynthesis, an E-cadherinprecursor
form (pE, 145 kD) predominates, but some of the lowerMr
mature E-cadherin can be seen, particularly in the pp60°-
lane of this exposure (Fig. 9 G, lane 3) .
The stability of newly synthesized E-cadherin was deter-
mined in a pulse-chase experiment. The half-times for loss
of 35S-methionine-labeled E-cadherin in stock, pp60c--
expressing, and ppó0°--expressing P19 cells were found
to be 5.6, 3.8, and 3.9 h, respectively. Thus, the higher level
of E-cadherin in these pp60--expressing P19 cells can be
accounted for by increased synthesis. The lower level of
E-cadherin in these pp60-.+-expressing P19 cells corre-
lates with the faster degradation rate.
The higher level of cell surface E-cadherin in pp60°-s--
expressing P19 cells correlates with the tighter cell packing
in monolayer cultures of pp60°--expressing P19 cells (Fig.
3 C). Likewise, lower cell surface levels of E-cadherin in
pp60°-s--expressing P19 cells correlates with less tight cell
packing in monolayer cultures of pp60c-Jrc`-expressing cells
(Fig. 3 B). However, pp60`-s
"c+- and pp60--expressing P19
cells do not have the low level of E-cadherin characteristic
of RAtreated P19 cells (Fig. 9 A, lane 3) .
Cell surface E-cadherin of aggregated P19 cells is de-
creased after RA treatment of stock, pp60°-Jrc-expressing,
and ppó0°---expressing P19 cells (Fig. 9 D). However, the
level of cell surface E-cadherin in RA-treated aggregates of
pp60"--expressing P19 cells is greater than in RA-treated
aggregates ofstock P19 cells (1.5-fold greater; Fig. 9D, lanes
2 and 6) . Thus, we could not correlate decreased cell-cell
adhesion observed in pp60°-frc-expressing P19 cell aggre-
gates with a decrease in the level of cell surface E-cadherin.
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Discussion
Cell-cell contact-dependent signals are an important but
mostly unexplored aspect of vertebrate neurogenesis. Our
results provide new insights into understanding neurogenesis
in the P19 embryonal carcinoma system and suggest that this
in vitro systemmaybe useful for the study ofcell-cell signals
involved in neurogenesis. First, we have found that there is
transient expression of an epithelial phenotype by cells in
RA-treated aggregates. Second, we have found that while
pp60-s- inhibits neuronal differentiation it does not inhibit
epithelial differentiation. Third, our results raise the possi-
bility that PTKs may modulate cell fate during RA-induced
differentiation by regulating calcium-dependent cell-cell
adhesion. We discuss each of these topics below.
Cell Fates ofRetinoicAcid-treatedP19 Cells
Differentiating P19 cells have characteristics in common
with multipotent cells of the early embryo. The inner cell
mass of the mouse embryo does not express significant num-
bers of intermediate filaments, as determined by EM (26) .
The calcium-dependent cell-cell adhesion molecule of the
inner cell mass and its two earliest derivatives (primitive ec-
toderm and endoderm) is E-cadherin (66). Both of these de-
rivatives express keratin filaments and desmosomes, al-
though the levels of these two structures are much lower in
primitive ectoderm (27). Mesodermal cells and neural cells
are derived from the primitive ectoderm by successive
phases of recruitment of cells from the ectoderm. When ec-
todermal cells commit to the mesodermal and neural line-
ages they lose expression of keratin filaments (27).
Undifferentiated P19 cells have previously been shown to
express some cell surface and intracellular markers that are
similar to those of primitive neuroectodermal cells (35) .
However, as judged by their pluripotency (58), E-cadherin
expression (Table 1), and low level ofintermediate filaments,
undifferentiated P19 cellsalso resemble cellsofthe inner cell
mass. Furthermore, P19 cells exposed to RA in the absence
Table I. Summary of Effects ofpp601- on the Retinoic
Acid-induced Diferëntiation ofP19-01A1 Cells
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Undifferentiated: non-RA-treated monolayer culture. Aggregated: 2-d RA-
treated floating aggregates. Differentiated: cells treated for neuronal differenti-
ation and assayed 11 d after exposure to RA. c-src and v-src: pp60`""`- and
pp60"-'rc-expressing P19-OIAI cells, respectively. ECAD, E-cadherin; NF,
























Figure 10. (A) The two putative cell-cell contact-dependent line-
ages ofretinoic acid-induced P19-OlAl cells. (B and C) Two means
by whichpp60v-s- might alter cell fate during retinoic acid-induced
differentiation of P19-OIAI cells.
ofclose cell-cell contact can differentiate into epithelialcells
(Fig. 10 A), as do cells of the inner cell mass. These con-
siderations, together with the fact that pp60°-s-expressing
P19 cells that were treated for neuronal differentiation were
found to have undergone epithelialdifferentiation, prompted
us to test if stock P19 cells might transiently express an epi-
thelial phenotype when induced for neuronal differentiation.
We have foundthat stock P19 cellsexposed to RA as float-
ing aggregates are induced to express keratin (Table I) . Also,
some desmoplakins become resistant to solubilization with
nonionic detergent, a property which correlates with the ap-
pearance of a punctate staining pattern located at regions of
cell-cell contact, consistent with formation of desmosomes.
However, levels of TROMA-1-reactive keratin in RA-treated
P19 cellsare lowerthan keratin levels in F9 embryonal carci-
noma cells. Thus, while RA-induced F9 cell differentiation
favors endodermal phenotypes (64), the lower levels of des-
mosomes and keratin expression in RA-treated and aggre-
gated P19 cells suggest that they may transiently have a
primitive ectodermal phenotype. We are further characteriz-
ing the epithelial phenotype of RA-treated and aggregated
P19 cells in order to test the hypothesis that the behavior of
these cells is analogous to the in vivo progression of inner
cell mass through primitive ectoderm to the neural lineage.
It has been reported that TROMA-1 antibody does not de-
tect keratin filaments in mouse primitive ectoderm in vivo
(30). TROMA-1 has been proposed as a probe specific for
Endo-A keratin in endoderm and trophectoderm of the early
embryo (30) . While some P19 cells exposed to RA in
monolayer culture (48, 50) or exposed to DMSO as ag-
gregates (61) undergo endodermal differentiation, it seems
unlikely that the transient epithelial cell type of RA-treated
P19 cell aggregates is endoderm or trophectoderm since
these cells are not on the neural lineage. It seems more likely
to us that the transient epithelial phenotype of RA-treated
and aggregated stock P19 cells is ectodermal and that the
Endo-A is either inappropriately expressed in this in vitro
system or that Endo-A is expressed at a low levelofectoderm
in vivo that escaped detection (30) . As for ectoderm in vivo,
terminal neural differentiation of stock P19 cells results in
loss of keratin expression and results in neurofilament ex-
pression (Table I). We conclude that P19 cells transiently as-
sume an epithelial phenotype before neural differentiation.
TheAlteration in P19 CellFate Mediatedbypp60-
It was previously shown that expression of pp60° -- does
not block epithelial (endodermal) differentiation ofF9 cells,
but does block RA-induced neuronal and dimethylsulfoxide-
Schmidt et al . pp60'm Modulates P19 Embryonal Carcinoma Cell Fate
induced muscle differentiation of P19 cells (5) . Boulter and
Wagner suggested that expression of pp60°-src might not in-
terfere with the earliest events ofmouse embryogenesis, only
later events such as neural differentiation. Our results are in
agreement with this idea and further define the point in P19
cell development at which expression of pp60v-sr° becomes
effective in blocking further differentiation events. Expres-
sion of pp60- or pp60c-,-' in undifferentiated P19 cells in-
hibits their capacity for neuronal differentiation. However,
pp60 1 rrc- and pp60c
-s--expressing P19 cells retain the ca-
pacity to differentiate into epithelial cells. Some of the non-
neural cellsin these cultures at latertimesafter treatment for
neuronal differentiation may be myofibroblastic or myo-
epithelial cells (59), although the proliferation of these cells
is greatly inhibited by growth of RA-treated stock P19 cells
in serum-free medium.
Two possibilities exist to account for the generation of
nonneuronal cells when pp60c-s-- or pp60°-s"r-expressing
P19 cells are treated for neuronal differentiation (Fig. 10).
One possibility is that they result from an alternatedifferenti-
ation pathway separate from the neural lineage (Fig. 10 B).
Alternatively, we have not ruled out the possibility that these
RA-induced, nonneuronal cells might be committed to the
neural lineage but blocked from progressing to a mature neu-
ronal phenotype (Fig. 10 C). Analysis of expression of addi-
tional marker proteins may clarify this question. For exam-
ple, a newly identifiedintermediate filament subtype (nestin)
has been found in neuroepithelial cells (34) . It will be of in-
terest to determine if neurofilament-negative P19 cells in
RA-treated cultures express nestin filaments.
While pp60-sr° is a nonphysiological probe of P19 cell
differentiation, it is of interest that pp60-rr over-expression
at least partially mimics the action of pp60 --, consistent
with the idea that regulated tyrosine phosphorylation may be
physiologically relevant in vertebrate neurogenesis. We con-
clude that some cells of pp60`- -expressing P19 sublines
and most cells of pp60 - rrc-expressing P19 sublines have an
altered fate under conditions that give neuronal differentia-
tion of stock P19 cells. It remains to be determined if this
modulation of P19 cell fate is due to exit from the neural lin-
eage or blocked progression within the neural lineage.
Cell-CellContact, Tyrosine Phosphorylation, and
Choice ofCellFate
Our results suggest that calcium-dependent cell-cell adhe-
sion is required during RA-induced neurogenesis in the P19
system. The role ofcell-cell interactions in neural induction
has been investigated in both invertebrate and vertebrate sys-
tems. In Xenopus, results indicative of the spread of a signal
laterally within the ectoderm have been described (60). Cell
disaggregation and reaggregation experiments with Xenopus
suggest a role for cell-cell contacts in ectoderm for neural
commitment (22) . Recent experiments suggest that cadhe-
rins can influence the recruitment ofectodermal cells to the
neural lineage in Xenopus (15). The P19 system may be use-
ful for identification ofa cadherin-dependent signal involved
in neurogenesis.
While many receptor PTKs have been shown to be acti-
vated by diffusible growth factors, PTKs may also be regu-
lated in a cell-cell contact-dependent manner (4). Trans-
membrane PTKs have been identified that are involved in
103 1neuronal differentiation (4) and survival (29, 31). A Dro-
sophila PTKlinked receptor that is activated-by the Elp mu-
tation allows differentiation of epithelial cells of the eye im-
aginal disk to yield pigment cells and bristles and inhibits
differentiation of sensory neurons and ommatidia of the eye
(3). However, in the same system, the sevenless PTK is re-
quired for the neuronal differentiation of R7 cells (4). Simi-
larly, in transfection experiments, EGF receptor has recently
been shown to promote neuronal differentiation of P19 cells
(14). Thus, various PTKs may have different effects in mul-
tipotential ectodermal precursor cells and committed neu-
roepithelial cells. The ability of pp60s- to weaken cell-cell
contacts in early epithelial precursor cells might indirectly
interfere with later neuralizing cell fate decisions that nor-
mally depend on the controlled cell-cell contact-dependent
activation of receptor-linked PTKs.
The pp60,s-- and pp60c-s--expressing P19 cells have de-
creased cell-cell contact in RA-treated aggr6gates. Em-
bryonic stem cells that express pp60°-s- have also been
shown to aggregate poorly (6) . We are now testing the hy-
pothesis that decreased cell-cell contact and cell-cell com-
munication is involved in the decreased capacity for neuronal
differentiation . Specific adhesion proteins like E-cadherin
are potential targets for pp60c-s- in P19 cells, but the ability
of pp60"-s.° and pp60`- s- to decrease cell-cell and cell-
substrate adhesion in many different cell types suggests that
a common element such as actin filament depolymerization
may be involved. It also seems likely that pp60`- has addi-
tional actions in pp60°-s--expressing P19 cells independent
of the decreased cell-cell contact at the aggregation stage,
such as direct inhibition of gap junction communication (18,
65) or NCAM function (7).
Our results with P19 cells suggest that pp60c-s- expres-
sion and activity must be kept low in ectodermal precursor
cells in orderfor close cell-cell contact and neurogenesis to
occur. RA may make P19 cells competent for neuronal
differentiation by increasing expression of keratin and other
proteins which are needed to provide the tightcell-cell con-
tact required for a neuralizing cell-cell signal. After commit-
ment, high levels of pp60`- may be a consequence of neu-
ral commitment and be involved in migration (7), process
elongation (2), and secretion (52). However, such proposed
roles for src may be shared by other src-family members
such asfyn and yes, since mice that do not express pp60-
show no gross neuroanatomical defects in the central or pe-
ripheral nervous systems (63, J. Deitch and J. S. Brugge, un-
published).
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